{"id":3637,"date":"2019-05-28T13:36:28","date_gmt":"2019-05-28T11:36:28","guid":{"rendered":"http:\/\/www.pharmin.sk\/?p=3637"},"modified":"2019-06-03T13:37:48","modified_gmt":"2019-06-03T11:37:48","slug":"skolenie-market-access-aj-pre-pracovnikov-medicinskych-a-marketingovych-oddeleni","status":"publish","type":"post","link":"https:\/\/www.pharmin.sk\/sk\/aktuality\/skolenie-market-access-aj-pre-pracovnikov-medicinskych-a-marketingovych-oddeleni\/","title":{"rendered":"\u0160kolenie MARKET ACCESS: (aj) pre pracovn\u00edkov medic\u00ednskych a marketingov\u00fdch oddelen\u00ed"},"content":{"rendered":"<p><strong>\u010co je Market Access?<\/strong><br \/>\nMarket Access je komplexn\u00fd proces, ktor\u00fd je potrebn\u00fd <strong>na zabezpe\u010denie \u00fahrady za lieky<\/strong> (alebo in\u00e9 zdravotn\u00edcke technol\u00f3gie) a ich dostupnosti pre pacientov.<\/p>\n<p><strong>Pre koho je \u0161kolenie ur\u010den\u00e9?<br \/>\n<\/strong>\u0160kolenie je ur\u010den\u00e9 pre <strong>v\u0161etk\u00fdch pracovn\u00edkov farmaceutick\u00fdch spolo\u010dnost\u00ed<\/strong>, ktor\u00ed sa vo svojej pr\u00e1ci stret\u00e1vaj\u00fa s problematikou vstupu nov\u00fdch zdravotn\u00edckych technol\u00f3gi\u00ed do syst\u00e9mu \u00fahrad, <strong>vr\u00e1tane pracovn\u00edkov z marketingov\u00fdch a medic\u00ednskych oddelen\u00ed.<\/strong><\/p>\n<p><strong>Pre\u010do je \u0161kolenie d\u00f4le\u017eit\u00e9?<\/strong><br \/>\nS oh\u013eadom na rast\u00face ceny liekov a\u00a0limitovan\u00e9 rozpo\u010dty zdravotn\u00fdch pois\u0165ovn\u00ed <strong>je st\u00e1le n\u00e1ro\u010dnej\u0161ie preuk\u00e1za\u0165 pridan\u00fa hodnotu liekov<\/strong> a\u00a0dosiahnu\u0165 <strong>zaradenie do syst\u00e9mu \u00fahrad<\/strong>. S oh\u013eadom na r\u00f4znorodos\u0165 \u010dinnost\u00ed, ktor\u00e9 je potrebn\u00e9 v Market Access zabezpe\u010di\u0165 je potrebn\u00e9, aby sa zabezpe\u010dila <strong>s\u00fa\u010dinnos\u0165 viacer\u00fdch odbornost\u00ed<\/strong> v\u00a0r\u00e1mci jednej spolo\u010dnosti.<\/p>\n<p><strong>\u010co v\u00e1m \u0161kolenie poskytne?<\/strong><br \/>\n\u0160kolenie poskytuje okrem z\u00e1kladn\u00fdch vedomosti a praktick\u00fdch zru\u010dnost\u00ed z oblasti Market Access aj<strong> mno\u017estvo pr\u00edkladov z\u00a0rozhodovacej praxe <\/strong>a\u00a0pom\u00f4\u017ee pripravova\u0165 \u017eiadosti o\u00a0\u00fahradu tak, aby sa naplnili legislat\u00edvne po\u017eiadavky a\u00a0o\u010dak\u00e1vania regul\u00e1torov a<strong> minimalizovalo sa tak riziko zamietnutia.<\/strong><\/p>\n<p><strong>Forma \u0161kolenia<\/strong><br \/>\n\u0160kolenie v\u00e1m priprav\u00edme cielene <strong>pre zamestnancov va\u0161ej spolo\u010dnosti<\/strong> s mo\u017enos\u0165ou <strong>prisp\u00f4sobenia obsahu<\/strong> pod\u013ea va\u0161ich potrieb a v\u00e1\u0161ho portf\u00f3lia. \u0160kolenie je 2-d\u0148ov\u00e9, av\u0161ak term\u00edn, d\u013a\u017eku a obsah \u0161kolenia vieme upravi\u0165 na z\u00e1klade vz\u00e1jomnej dohody.<\/p>\n<p><strong>Kde n\u00e1jdem viac inform\u00e1ci\u00ed?<br \/>\n<\/strong>Viac inform\u00e1ci\u00ed o\u00a0\u0161kolen\u00ed n\u00e1jdete <u><a href=\"https:\/\/www.pharmin.sk\/sk\/skolenia\/zaklady-market-access\/\">na\u0161ej str\u00e1nke<\/a><\/u>.<\/p>\n<p><strong>Term\u00edn \u0161kolenia<\/strong><br \/>\nV s\u00fa\u010dasnosti vieme poskytn\u00fa\u0165 limitovan\u00fd po\u010det term\u00ednov \u0161kolen\u00ed na <strong>jese\u0148 2019<\/strong>.<\/p>\n<p><strong>Ako sa prihl\u00e1si\u0165?<\/strong><br \/>\nPrihl\u00e1si\u0165 sa m\u00f4\u017eete jednoducho. Sta\u010d\u00ed ak n\u00e1m nap\u00ed\u0161ete na na\u0161u <a href=\"mailto:pharmin@pharmin.sk\">emailov\u00fa adresu<\/a> a\u00a0my v\u00e1s budeme kontaktova\u0165.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u010co je Market Access? Market Access je komplexn\u00fd proces, ktor\u00fd je potrebn\u00fd na zabezpe\u010denie \u00fahrady za lieky (alebo in\u00e9 zdravotn\u00edcke technol\u00f3gie) a ich dostupnosti pre pacientov. Pre koho je \u0161kolenie ur\u010den\u00e9? \u0160kolenie je ur\u010den\u00e9 pre v\u0161etk\u00fdch pracovn\u00edkov farmaceutick\u00fdch spolo\u010dnost\u00ed, ktor\u00ed sa vo svojej pr\u00e1ci stret\u00e1vaj\u00fa s problematikou vstupu nov\u00fdch zdravotn\u00edckych technol\u00f3gi\u00ed do syst\u00e9mu \u00fahrad, vr\u00e1tane<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3637","post","type-post","status-publish","format-standard","hentry","category-aktuality"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/3637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/comments?post=3637"}],"version-history":[{"count":0,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/3637\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/media?parent=3637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/categories?post=3637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/tags?post=3637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}